Improving HIV treatment and research capacity in Botswana
Official title: Developing Botswana Laboratory Capacity in HIV Genomics and HIV Cure
Funded at Botswana-Harvard AIDS Institute · NIH-11064049 · Data updated 2026-11-12
This study is all about improving how we understand and treat HIV in Botswana, especially for young people, by training local experts and using new technology to learn more about the virus's genetics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Botswana-Harvard AIDS Institute NIH-funded |
| Lab location | 1 site (Gaborone, Botswana) |
| Project start | May 15, 2023 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $99,403 |
| NIH project number | 5G11TW012503-03 |
| Project ID | NIH-11064049 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adolescents and young adults living with HIV in Botswana, particularly those who have received early treatment.
✕Less likely to help
Patients who are not living with HIV or those outside the age range of adolescents and young adults may not benefit from this research.
What this research studies
This research focuses on enhancing laboratory capabilities in Botswana to better understand and treat HIV. It aims to provide advanced training in HIV genomics and improve access to cutting-edge technologies for analyzing the virus. By leveraging local expertise and international collaboration, the project seeks to develop innovative strategies for HIV prevention and treatment, particularly for adolescents and young people. The research will also involve studying the genetic makeup of HIV in Botswana to inform future therapeutic approaches.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for individuals living with HIV in Botswana.
How similar studies have gone: Previous research has shown success in enhancing HIV treatment outcomes through improved laboratory capabilities and genomics, making this approach promising.
Where this research is happening
-
Botswana-Harvard AIDS Institute
Gaborone, Botswana Active
Researchers
- Principal investigator: Gaseitsiwe, Simani — Botswana-Harvard AIDS Institute
- Study coordinator: Gaseitsiwe, Simani
Related research
Other NIH-funded projects on the same topics.
-
Exploring ways to cure HIV in adolescents on long-term treatment in Botswana
This study is looking at teenagers with HIV-1 who have been on treatment since they were young, to learn more about how the virus stays in their bodies and to find out if some of them have a lower amount of the virus; if you join, you might also get a chance to try out new treatment options.
-
Improving HIV prevention for pregnant women in Botswana
This study is looking at ways to help pregnant women in Botswana use HIV prevention methods more easily, by combining STI testing with PrEP services during their check-ups, so they can stay healthy and protect their babies.
-
Using viral diversity to improve estimates of HIV incidence
This study is looking at new ways to understand how HIV spreads by examining the differences in the virus, which could help improve tools for fighting HIV and possibly finding a cure, while also exploring insights that could be useful for COVID-19.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.